Arresting the development of morphine tolerance and dependence

British Journal of Anaesthesia

Volumn 107, Issue 5, 2011, Pages 653-655

  Hales, T G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; ONDANSETRON;

ANALGESIA; CANCER PATIENT; DRUG TOLERANCE; HUMAN; HYPERALGESIA; MORPHINE ADDICTION; NONHUMAN; PAIN; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 80054094354     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer294     Document Type: Editorial

References (21)

1. Stein C, Schäfer M, Machelska H. Why is morphine not the ultimate analgesic and what can be done to improve it? J Pain 2000;1:51-6
2. Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Phys 2008;11:S181-200
3. McDougall JJ. Peripheral analgesia: hitting pain where it hurts. Biochim Biophys Acta 2011;1812:459-67
4. Dietis N, Rowbotham DJ, Lambert DG. Opioid receptor subtypes: fact or artifact? Br J Anaesth 2011;107:8-18
5. Yuan CS, Wei G, Foss JF, O'Connor M, Karrison T, Osinski J. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebocontrolled trial. J Pharmacol Exp Ther 2002;300:118-23
6. Carstensen M, Møller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anaesth 2010;104:401-6
7. Liang DY, Li X, Clark JD. 5-Hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. Anesthesiology 2011;114:1180-9
8. Dietis N, Guerrini R, Calo G, Salvadori S, Rowbotham DJ, Lambert DG. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth 2009;103:38-49
9. Heinke B, Gingl E, Sandkühler J. Multiple targets of μ-opioid receptor-mediated presynaptic inhibition at primary afferent Aδ-and C-fibers. J Neurosci 2011;31:1313-22
10. Yang C-H, Huang W-W, Chen K-H, Chen Y-S, Sheen-Chen S-M, Lin C-R. Antinociceptive potentiation and attenuation of tolerance by intrathecal b-arrestin 2 small interfering RNA in rats. Br J Anaesth 2011;107:774-81
11. Pierce KL, Lefkowitz RJ. Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2001;2:727-33
12. Zuo Z. The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance. Anesth Analg 2005;101:728-34
13. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 1999;286:2495-8
14. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 2000;408:720-3
15. Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta) arrestin-2 knock-out mice. J Neurosci 2002;22:10494-500
16. Raehal KM, Walker JK, Bohn LM. Morphine side effects in beta-arrestin 2 knockout mice. J Pharmacol Exp Ther 2005;314:1195-201
17. Raehal KM, Bohn LM. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology 2011;60:58-65
18. Lam H, Maga M, Pradhan A, et al. Analgesic tone conferred by constitutively active μ opioid receptors in mice lacking β-arrestin 2. Mol Pain 2011;7:24
19. Walwyn W, Evans CJ, Hales TG. β-Arrestin2 and c-Src regulate the constitutive activity and recycling of μ opioid receptors in dorsal root ganglion neurons. J Neurosci 2007;27:5092-104
20. Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 2011;336:296-302
21. Groer CE, Tidgewell K, Moyer RA, et al. An opioid agonist that does not induce mu-opioid receptor-arrestin interactions or receptor internalization. Mol Pharmacol 2007;71:549-57